Medication Adherence in Patients With Liver Cirrhosis

NCT03627338 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2020-03-12

No results posted yet for this study

Summary

With this unfunded, investigator-initiated prospective, observational, explorative, single-arm and diagnostic single-centre study the investigators aim to evaluate medication adherence in patients with advanced liver cirrhosis

Conditions

  • Medication Adherence

Interventions

DIAGNOSTIC_TEST

questionaire, interview

questionaire, interview

Sponsors & Collaborators

  • Hannover Medical School

    lead OTHER

Principal Investigators

  • Benjamin Maasoumy, Associate Professor, MD · Medical School of Hannover

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-09-01
Primary Completion
2021-03-31
Completion
2021-05-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03627338 on ClinicalTrials.gov